JP2009535049A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009535049A5 JP2009535049A5 JP2009508461A JP2009508461A JP2009535049A5 JP 2009535049 A5 JP2009535049 A5 JP 2009535049A5 JP 2009508461 A JP2009508461 A JP 2009508461A JP 2009508461 A JP2009508461 A JP 2009508461A JP 2009535049 A5 JP2009535049 A5 JP 2009535049A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- drug
- dna
- pcr
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 claims 17
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 16
- 239000003814 drug Substances 0.000 claims 14
- 229940079593 drugs Drugs 0.000 claims 14
- 210000004369 Blood Anatomy 0.000 claims 9
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 9
- 239000008280 blood Substances 0.000 claims 9
- 230000001605 fetal Effects 0.000 claims 9
- 238000003752 polymerase chain reaction Methods 0.000 claims 9
- 230000011987 methylation Effects 0.000 claims 8
- 238000007069 methylation reaction Methods 0.000 claims 8
- 230000003321 amplification Effects 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims 6
- 230000035935 pregnancy Effects 0.000 claims 5
- 108090000790 Enzymes Proteins 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 4
- 208000001362 Fetal Growth Retardation Diseases 0.000 claims 4
- 206010070531 Foetal growth restriction Diseases 0.000 claims 4
- 108091007521 restriction endonucleases Proteins 0.000 claims 4
- 101700075287 CASP8 Proteins 0.000 claims 3
- 102100008990 CASP8 Human genes 0.000 claims 3
- -1 DAB21P Proteins 0.000 claims 3
- 102100003367 PTPN6 Human genes 0.000 claims 3
- 101710033203 PTPN6 Proteins 0.000 claims 3
- 101710006673 PYCARD Proteins 0.000 claims 3
- 102100011915 PYCARD Human genes 0.000 claims 3
- 102100000510 RARB Human genes 0.000 claims 3
- 101700058821 RARB Proteins 0.000 claims 3
- 102100018034 SCGB3A1 Human genes 0.000 claims 3
- 101710022291 SCGB3A1 Proteins 0.000 claims 3
- 102100008333 THY1 Human genes 0.000 claims 3
- 101700026084 THY1 Proteins 0.000 claims 3
- 102100018591 TMEFF2 Human genes 0.000 claims 3
- 101710023903 TMEFF2 Proteins 0.000 claims 3
- 238000003753 real-time PCR Methods 0.000 claims 3
- 102100007788 APC Human genes 0.000 claims 2
- 101700010938 APC Proteins 0.000 claims 2
- 235000009825 Annona senegalensis Nutrition 0.000 claims 2
- 208000006399 Premature Obstetric Labor Diseases 0.000 claims 2
- 210000002593 Y Chromosome Anatomy 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 201000011461 pre-eclampsia Diseases 0.000 claims 2
- 210000003754 Fetus Anatomy 0.000 claims 1
- 210000002381 Plasma Anatomy 0.000 claims 1
- 210000003296 Saliva Anatomy 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
- 210000002700 Urine Anatomy 0.000 claims 1
Claims (31)
- 妊娠女性由来の生物試料中の胎児DNAを検出する方法であって、
(a)メチル化DNA及び非メチル化DNAを別個に修飾する薬物で該試料を処置し;及び
(b)該試料中のRASSF1A、APC、CASP8、RARB、SCGB3A1、DAB21P、PTPN6、THY1、TMEFF2又はPYCARDのDNA配列を検出し、ここで、該DNA配列の存在が試料中の胎児DNAの存在を指示し、該DNA配列の不存在が試料中の胎児DNAの不存在を指示する
工程を含む前記方法。 - 前記試料が全血、血漿、血清、尿、及び唾液からなる群から選択される、請求項1に記載の方法。
- 前記薬物が非メチル化DNAを消化するが、メチル化DNAを消化しない、請求項1に記載の方法。
- 前記薬物がメチル化感受性酵素である、請求項3に記載の方法。
- 前記メチル化感受性酵素がメチル化感受性制限酵素である、請求項4に記載の方法。
- 前記メチル化感受性制限酵素がHpaII又はBstUIである、請求項5に記載の方法。
- 前記薬物が亜硫酸水素塩を含む、請求項1に記載の方法。
- 工程(b)が増幅プロセスを含む、請求項1に記載の方法。
- 前記増幅プロセスがポリメラーゼ連鎖反応(PCR)である、請求項8に記載の方法。
- 前記PCRがリアルタイムPCRである、請求項9に記載の方法。
- 工程(b)がDNA配列の量を測定する、請求項1に記載の方法。
- 工程(b)が試料中の胎児DNAの存在を指示し、さらに、
(c)第2試料中の第2胎児DNA配列の量を測定し、ここで、第2試料が薬物で処理される前の工程(a)の試料と同一であり、第2配列がRASSF1A、APC、CASP8、RARB、SCGB3A1、DAB21P、PTPN6、THY1、TMEFF2又はPYCARDでなく;及び
(d)該2配列の量と標準対照とを比較し、ここで、対照からの第2配列の量の増加が妊娠に関連した状態の存在又はそれを発症する危険性の増加を指示する
工程を含む、請求項1に記載の方法。 - 前記工程(c)の第2試料が、メチル化DNA及び非メチル化DNAを別個に修飾するいずれの薬物でも処理されていない、請求項12に記載の方法。
- 前記工程(c)の第2試料が、第2胎児DNA配列の量が測定される前に、薬物で処理される請求項12に記載の方法。
- 前記工程(c)の第2試料が、第2胎児DNA配列の量が測定される前に、メチル化DNA及び非メチル化DNAを別個に修飾する第2の異なった薬物で処理される、請求項12に記載の方法。
- 妊娠に関連した状態が、子癇前症、早期陣痛又は子宮内発育遅延(IUGR)である、請求項12に記載の方法。
- 工程(b)が試料中の胎児DNAの存在を指示し、さらに、
(c)第2試料中の第2胎児DNAを検出し、ここで、第2試料が薬物で処理される前の工程(a)の試料と同一であり、第2配列がRhD血液型の遺伝子、ABO血液型の遺伝子、RhC血液型の遺伝子、RhE血液型の遺伝子、HLA型の遺伝子、Y染色体上に位置した遺伝子、又は所定の突然変異を含む遺伝子であり、第2配列の存在が胎児ゲノム中にRhD血液型、ABO血液型、RhC血液型、RhE血液型、HLA型、Y染色体又は突然変異の存在を指示する
工程を含む、請求項1に記載の方法。 - 工程(c)の第2試料がメチル化DNA及び非メチル化DNAを別個に修飾するいずれの薬物でも処理されていない、請求項17に記載の方法。
- 工程(c)が増幅プロセスである、請求項17に記載の方法。
- 前記増幅プロセスがポリメラーゼ連鎖反応(PCR)である、請求項19に記載の方法。
- PCRがリアルタイムPCRである、請求項20に記載の方法。
- 妊娠女性における妊娠に関連した状態を検出する方法であって、
(a)メチル化DNA及び非メチル化DNAを別個に修飾する薬物で女性から得た生物試料を処理し;
(b)該試料中のRASSF1A、CASP8、RARB、SCGB3A1、DAB21P、PTPN6、THY1、TMEFF2又はPYCARDのDNA配列の量を検出し;及び
(c)該DNA配列の量と標準対照とを比較し、ここで、対照からの増加が妊娠に関連した状態の存在又はそれを発症する危険性の増加を指示する
工程を含む前記方法。 - 前記薬物が非メチル化DNAを消化するが、メチル化DNAを消化しない、請求項22に記載の方法。
- 前記薬物がメチル化感受性酵素である、請求項23に記載の方法。
- 前記メチル化感受性酵素がメチル化感受性制限酵素である、請求項24に記載の方法。
- 前記メチル化感受性制限酵素がHpaII又はBstUIである、請求項25に記載の方法。
- 前記薬物が亜硫酸水素塩を含む、請求項22に記載の方法。
- 工程(b)が増幅プロセスを含む、請求項22に記載の方法。
- 前記増幅プロセスがポリメラーゼ連鎖反応(PCR)である、請求項28に記載の方法。
- 前記PCRがリアルタイムPCRである、請求項29に記載の方法。
- 妊娠に関連した状態が、子癇前症、早期陣痛又は子宮内発育遅延(IUGR)である、請求項22に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79750606P | 2006-05-03 | 2006-05-03 | |
US11/784,501 US7754428B2 (en) | 2006-05-03 | 2007-04-06 | Fetal methylation markers |
PCT/GB2007/001625 WO2007132166A2 (en) | 2006-05-03 | 2007-05-03 | New fetal methylation markers |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009535049A JP2009535049A (ja) | 2009-10-01 |
JP2009535049A5 true JP2009535049A5 (ja) | 2010-06-24 |
Family
ID=38444310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009508461A Pending JP2009535049A (ja) | 2006-05-03 | 2007-05-03 | 新規胎児メチル化マーカー |
Country Status (11)
Country | Link |
---|---|
US (3) | US7754428B2 (ja) |
EP (6) | EP3133173B1 (ja) |
JP (1) | JP2009535049A (ja) |
CN (1) | CN101512014B (ja) |
AU (1) | AU2007251394B2 (ja) |
CA (3) | CA2651049C (ja) |
DK (1) | DK2016190T3 (ja) |
ES (3) | ES2608954T3 (ja) |
HK (1) | HK1126249A1 (ja) |
MX (1) | MX2008013897A (ja) |
WO (1) | WO2007132166A2 (ja) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2739483T3 (es) | 2006-02-02 | 2020-01-31 | Univ Leland Stanford Junior | Detección genética fetal no invasiva mediante análisis digital |
US7754428B2 (en) * | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
EP2029779A4 (en) | 2006-06-14 | 2010-01-20 | Living Microsystems Inc | HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS |
TWI335354B (en) * | 2006-09-27 | 2011-01-01 | Univ Hong Kong Chinese | Methods for the detection of the degree of the methylation of a target dna and kits |
DK2514842T3 (en) | 2007-07-23 | 2016-05-30 | Univ Hong Kong Chinese | Diagnosis of fetal chromosomal aneuploidy using genome sequencing |
US20100112590A1 (en) | 2007-07-23 | 2010-05-06 | The Chinese University Of Hong Kong | Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment |
US9218449B2 (en) | 2007-07-23 | 2015-12-22 | The Chinese University Of Hong Kong | Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis |
MX2010003718A (es) * | 2007-10-19 | 2010-04-21 | Genentech Inc | Anticuerpos anti-tenb2 producidos por ingenieria de cisteina y conjugados de farmaco y anticuerpo. |
KR20220008944A (ko) | 2008-01-18 | 2022-01-21 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법 |
CA2752838A1 (en) * | 2008-02-18 | 2009-08-27 | Genetic Technologies Limited | Cell processing and/or enrichment methods |
AU2009293232B2 (en) * | 2008-09-16 | 2015-05-14 | Sequenom Center For Molecular Medicine | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US8476013B2 (en) * | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
CA3069082C (en) | 2008-09-20 | 2022-03-22 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
SG175282A1 (en) | 2009-04-21 | 2011-11-28 | Genetic Technologies Ltd | Methods for obtaining fetal genetic material |
AU2015252141A1 (en) * | 2009-09-16 | 2015-12-03 | Sequenom Center For Molecular Medicine | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
WO2011066476A1 (en) * | 2009-11-25 | 2011-06-03 | Quantalife, Inc. | Methods and compositions for detecting genetic material |
US9926593B2 (en) | 2009-12-22 | 2018-03-27 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
US20110312503A1 (en) | 2010-01-23 | 2011-12-22 | Artemis Health, Inc. | Methods of fetal abnormality detection |
GB201007944D0 (en) | 2010-05-12 | 2010-06-30 | Univ Aberystwyth | Methods |
JP2013538565A (ja) | 2010-07-23 | 2013-10-17 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | 体液中の疾患または症状のシグネチャを検出する方法 |
CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
WO2012012725A2 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
US20130184178A1 (en) | 2010-07-23 | 2013-07-18 | President And Fellows Of Harvard College | Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions |
US20130261003A1 (en) | 2010-08-06 | 2013-10-03 | Ariosa Diagnostics, In. | Ligation-based detection of genetic variants |
US20120034603A1 (en) | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
US11203786B2 (en) | 2010-08-06 | 2021-12-21 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
US20140342940A1 (en) | 2011-01-25 | 2014-11-20 | Ariosa Diagnostics, Inc. | Detection of Target Nucleic Acids using Hybridization |
US10533223B2 (en) | 2010-08-06 | 2020-01-14 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
US20130040375A1 (en) | 2011-08-08 | 2013-02-14 | Tandem Diagnotics, Inc. | Assay systems for genetic analysis |
US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
US11031095B2 (en) | 2010-08-06 | 2021-06-08 | Ariosa Diagnostics, Inc. | Assay systems for determination of fetal copy number variation |
US10167508B2 (en) | 2010-08-06 | 2019-01-01 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
CN102002524B (zh) * | 2010-11-11 | 2012-06-06 | 浙江大学 | 一种dab2ip基因的实时荧光pcr检测试剂盒及检测方法 |
US9994897B2 (en) | 2013-03-08 | 2018-06-12 | Ariosa Diagnostics, Inc. | Non-invasive fetal sex determination |
US8756020B2 (en) | 2011-01-25 | 2014-06-17 | Ariosa Diagnostics, Inc. | Enhanced risk probabilities using biomolecule estimations |
US11270781B2 (en) | 2011-01-25 | 2022-03-08 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
US10131947B2 (en) | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
EP3940084A1 (en) | 2011-02-09 | 2022-01-19 | Bio-Rad Laboratories, Inc. | Analysis of nucleic acids |
EP3489368B1 (en) | 2011-02-24 | 2020-09-09 | The Chinese University Of Hong Kong | Molecular testing of multiple pregnancies |
US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
WO2013082308A1 (en) | 2011-11-30 | 2013-06-06 | Children's Hospital Medical Center | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support |
US9546403B1 (en) * | 2011-12-14 | 2017-01-17 | University Of Utah Research Foundation | Substrate for methylated DNA testing |
EP2820157B1 (en) | 2012-03-02 | 2019-05-01 | Winthrop-University Hospital | Method for using probe based pcr detection to measure the levels of circulating demethylated beta cell derived dna as a measure of beta cell loss in diabetes |
EP3401399B1 (en) | 2012-03-02 | 2020-04-22 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10289800B2 (en) | 2012-05-21 | 2019-05-14 | Ariosa Diagnostics, Inc. | Processes for calculating phased fetal genomic sequences |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
US20140093873A1 (en) | 2012-07-13 | 2014-04-03 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
WO2014015269A1 (en) | 2012-07-19 | 2014-01-23 | Ariosa Diagnostics, Inc. | Multiplexed sequential ligation-based detection of genetic variants |
US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
MX360034B (es) * | 2012-09-20 | 2018-10-19 | Univ Hong Kong Chinese | Determinacion no invasiva del metiloma fetal o de tumor de plasma. |
US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
EP2965077B1 (en) | 2013-03-09 | 2022-07-13 | Harry Stylli | Methods of detecting cancer |
EP2965086A4 (en) | 2013-03-09 | 2017-02-08 | Harry Stylli | Methods of detecting prostate cancer |
EP3597774A1 (en) | 2013-03-13 | 2020-01-22 | Sequenom, Inc. | Primers for dna methylation analysis |
WO2015002845A1 (en) * | 2013-07-01 | 2015-01-08 | Anderson Cindy | Biomarker for preeclampsia |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
CA2940422A1 (en) | 2014-02-24 | 2015-08-27 | Children's Hospital Medical Center | Methods and compositions for personalized pain management |
WO2015138774A1 (en) | 2014-03-13 | 2015-09-17 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
CN104031985B (zh) * | 2014-04-15 | 2016-06-22 | 山东省农业科学院奶牛研究中心 | 检测体细胞核移植胚胎发育能力的引物、试剂盒及方法 |
EP3134541B1 (en) | 2014-04-21 | 2020-08-19 | Natera, Inc. | Detecting copy number variations (cnv) of chromosomal segments in cancer |
US10801067B2 (en) | 2014-05-09 | 2020-10-13 | Eurofins Lifecodexx Gmbh | Detection of DNA that originates from a specific cell-type and related methods |
EP2942401A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Detection of DNA that originates from a specific cell-type |
EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
EP3191846A4 (en) | 2014-09-11 | 2018-06-13 | Harry Stylli | Methods of detecting prostate cancer |
US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
KR101546364B1 (ko) | 2015-03-16 | 2015-09-02 | 의료법인 제일의료재단 | 태아 특이적 후성학적 메틸화 마커 검출용 조성물 및 검출방법 |
EP3168309B8 (en) | 2015-11-10 | 2020-06-03 | Eurofins LifeCodexx GmbH | Detection of foetal chromosomal aneuploidies using dna regions that are differentially methylated between the foetus and the pregnant female |
TWI648403B (zh) * | 2016-07-29 | 2019-01-21 | 臺北醫學大學 | 婦科腫瘤的診斷方法 |
WO2018136728A1 (en) * | 2017-01-20 | 2018-07-26 | Children's Hospital Medical Center | Methods and compositions relating to oprm1 dna methylation for personalized pain management |
CN109825581A (zh) * | 2019-02-28 | 2019-05-31 | 昆明理工大学 | 一种检测rassf1a基因甲基化的引物、检测方法、试剂盒及应用 |
RU2697845C1 (ru) * | 2019-05-17 | 2019-08-21 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Прогнозирование преэклампсии на основе определения внеклеточной ДНК плода в материнской крови при проведении скрининга первого триместра беременности |
CN110229908B (zh) * | 2019-07-03 | 2023-01-31 | 四川沃文特生物技术有限公司 | 用于早期检测肺癌基因甲基化的引物、探针及试剂盒 |
CA3225014A1 (en) | 2021-08-02 | 2023-02-09 | Georgina GOLDRING | Methods for detecting neoplasm in pregnant women |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
US20030211522A1 (en) | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
US6977162B2 (en) * | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
WO2004031402A2 (en) * | 2002-10-02 | 2004-04-15 | Northwestern University | Methylation profile of cancer |
US7718364B2 (en) | 2003-03-25 | 2010-05-18 | John Wayne Cancer Institute | DNA markers for management of cancer |
AU2004284456B2 (en) * | 2003-10-21 | 2012-04-19 | Orion Genomics Llc | Methods for quantitative determination of methylation density in a DNA locus |
US7709194B2 (en) | 2004-06-04 | 2010-05-04 | The Chinese University Of Hong Kong | Marker for prenatal diagnosis and monitoring |
EP1869222A4 (en) * | 2005-04-15 | 2010-01-20 | Oncomethylome Sciences S A | METHYLATION MARKERS FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
US7754428B2 (en) * | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
-
2007
- 2007-04-06 US US11/784,501 patent/US7754428B2/en active Active
- 2007-05-03 EP EP16186367.5A patent/EP3133173B1/en active Active
- 2007-05-03 EP EP23200691.6A patent/EP4289969A2/en active Pending
- 2007-05-03 ES ES07732658.5T patent/ES2608954T3/es active Active
- 2007-05-03 CA CA2651049A patent/CA2651049C/en active Active
- 2007-05-03 CN CN2007800160259A patent/CN101512014B/zh active Active
- 2007-05-03 CA CA2982978A patent/CA2982978C/en active Active
- 2007-05-03 ES ES16186367.5T patent/ES2658815T3/es active Active
- 2007-05-03 JP JP2009508461A patent/JP2009535049A/ja active Pending
- 2007-05-03 DK DK07732658.5T patent/DK2016190T3/en active
- 2007-05-03 EP EP21159274.6A patent/EP3875604B1/en active Active
- 2007-05-03 MX MX2008013897A patent/MX2008013897A/es active IP Right Grant
- 2007-05-03 AU AU2007251394A patent/AU2007251394B2/en active Active
- 2007-05-03 EP EP19154251.3A patent/EP3505644B1/en active Active
- 2007-05-03 WO PCT/GB2007/001625 patent/WO2007132166A2/en active Application Filing
- 2007-05-03 EP EP07732658.5A patent/EP2016190B1/en active Active
- 2007-05-03 EP EP17196195.6A patent/EP3299477B1/en active Active
- 2007-05-03 CA CA3048335A patent/CA3048335A1/en active Pending
- 2007-05-03 ES ES17196195T patent/ES2724128T3/es active Active
-
2009
- 2009-05-14 HK HK09104395.4A patent/HK1126249A1/zh unknown
-
2010
- 2010-06-01 US US12/791,776 patent/US8288100B2/en active Active
-
2012
- 2012-09-14 US US13/618,527 patent/US8927216B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009535049A5 (ja) | ||
JP5789605B2 (ja) | 染色体異数性の検出方法 | |
US8288100B2 (en) | Methods for detecting fetal DNA in a plasma or serum sample from a pregnant woman | |
ES2385867T3 (es) | Método y kit para cuantificación molecular de cromosomas | |
EP1668154B1 (en) | Methods useful for detecting an alteration in a locus copy number | |
JP2009535050A5 (ja) | ||
US20140193817A1 (en) | Methods and kits useful for detecting an alteration in a locus copy number | |
JP2017514499A5 (ja) | ||
JP2013505019A5 (ja) | ||
JP2012502631A5 (ja) | ||
WO2008157264A2 (en) | Combined methods for the detection of chromosomal aneuploidy | |
US10876169B2 (en) | Method and kit for estimating the amount of a methylated locus in a sample | |
US20230160011A1 (en) | Method for evaluating and predicting placenta-derived diseases and kit | |
Krygier et al. | A simple modification to improve the accuracy of methylation-sensitive restriction enzyme quantitative polymerase chain reaction | |
TW201819638A (zh) | 以表觀遺傳區分dna | |
KR101695347B1 (ko) | 유전자의 CpG 메틸화 변화를 이용한 조산 위험성 예측용 조성물 및 이의 이용 | |
Wu et al. | X-chromosome inactivation in female newborns conceived by assisted reproductive technologies | |
Banerjee et al. | Fetal nucleic acids in maternal circulation: A genetic resource for noninvasive prenatal diagnosis | |
KR102268666B1 (ko) | 다운증후군 진단용 바이오마커 조성물 및 이의 용도 | |
Eshwarachary et al. | Noninvasive prenatal testing (NIPT) detects variant of Turner syndrome not detectable by florescence in situ hybridization | |
CN117004708A (zh) | 遗传性Imerslund-Grasbeck综合征的筛查方法、检测组合物及检测试剂盒 | |
Yuen | Epigenetics of human fetal and placental development | |
JP2009165409A (ja) | 不妊症患者精子におけるインプリント異常発生リスクの判定方法 | |
van den Oever | Noninvasive prenatal detection of genetic defects. | |
YUEN et al. | GENOME-WIDE MAPPING |